Merck (MRK) recently received a boost in the form of US Food and Drug Administration (FDA) approval for its chronic hepatitis C virus (HCV) drug, Victrelis (boceprevir). The FDA approved Victrelis for use in both treatment-na
FDA Approval for Merck’s Victrelis (MRK) (VRTX)
Be the first to comment